| 1 |
Gauthier JM, Li W, Hsiao HM, et al. Mechanisms of graft rejection and immune regulation after lung transplant [J]. Ann Am Thorac Soc, 2017, 14(S3): S216-S219.
|
| 2 |
Saldanha IJ, Akinyede O, Robinson KA. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis[J]. Cochrane Database Syst Rev, 2018, 6(6): CD009421.
|
| 3 |
Chen-Yoshikawa TF. Ischemia-reperfusion injury in lung transplantation[J]. Cells, 2021, 10(6)：1333.
|
| 4 |
Hashimoto K, Yamane M, Sugimoto S, et al. Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model[J]. Transpl Immunol, 2019, 57: 101242.
|
| 5 |
Tan J, Gao W, Yang W, et al. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway[J]. J Thorac Cardiovasc Surg, 2021, 162(2): e143-e156.
|
| 6 |
Kim H, Zhao J, Zhang Q, et al. δV1-1 reduces pulmonary ischemia reperfusion-induced lung injury by inhibiting necrosis and mitochondrial localization of PKCδ and p53[J]. Am J Transplant, 2016, 16(1): 83-98.
|
| 7 |
Wu H, Zhang R, Fan X, et al. FoxOs could play an important role during influenza A viruses infection via microarray analysis based on GEO database[J]. Infect Genet Evol, 2019, 75: 104009.
|
| 8 |
Shao L, Akkari Y, Cooley LD, et al. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2021, 23(10)：1818-1829.
|
| 9 |
Chen WW, Huang YF, Hu ZB, et al. Microarray analysis of altered long non-coding RNA expression profile in liver cancer cells treated by ginsenoside Rh2[J]. J Asian Nat Prod Res, 2019, 21(8): 742-753.
|
| 10 |
Guo Q, Ke XX, Liu Z, et al. Evaluation of the prognostic value of STEAP1 in lung adenocarcinoma and insights into its potential molecular pathways via bioinformatic analysis[J]. Front Genet, 2020，11: 242.
|
| 11 |
Ying XD, Wei G, An H. Sodium butyrate relieves lung ischemia-reperfusion injury by inhibiting NF-κB and JAK2/STAT3 signaling pathways[J]. Eur Rev Med Pharmacol Sci, 2021, 25(1): 413-422.
|
| 12 |
Kohmoto J, Nakao A, Stolz DB, et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway[J]. Am J Transplant, 2007, 7(10): 2279-2290.
|
| 13 |
Matsuo S, Chaung A, Liou D, et al. Inhibition of ubiquitin-activating enzyme protects against organ injury after intestinal ischemia-reperfusion[J]. Am J Physiol Gastrointest Liver Physiol, 2018, 315(2): G283-G292.
|
| 14 |
Takahashi M, Chen-Yoshikawa TF, Menju T, et al. Inhibition of Toll-like receptor 4 signaling ameliorates lung ischemia-reperfusion injury in acute hyperglycemic conditions[J]. J Heart Lung Transplant, 2016, 35(6): 815-822.
|
| 15 |
Liu J, Chen T, Lei P, et al. Exosomes released by bone marrow mesenchymal stem cells attenuate lung injury induced by intestinal ischemia reperfusion via the TLR4/NF-κB pathway[J]. Int J Med Sci, 2019, 16(9): 1238-1244.
|
| 16 |
Verleden SE, Martens A, Ordies S, et al. Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation[J]. Clin Transplant, 2018, 32(4): e13219.
|
| 17 |
Sharma AK, Mulloy DP, Le LT, et al. NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 306(1): L69-L79.
|
| 18 |
Chen X, Huang J. Mangiferin inhibits hypoxia/reoxygenation-induced alveolar epithelial cell injury via the SIRT1/AMPK signaling pathway[J]. Exp Ther Med, 2021, 22(5): 1220.
|
| 19 |
Chang JE, Kim HJ, Yi E, et al. Reduction of ischaemia-reperfusion injury in a rat lung transplantation model by low-concentration GV1001[J]. Eur J Cardiothorac Surg, 2016, 50(5): 972-979.
|